Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 1/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Aspiration bone marrow, Guillain-Barre syndrome, Intensive care, Mood altered, Paralysis, Systemic lupus erythematosus, Face injury
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Hospitalized? Yes, days:
Write-up:This spontaneous report was received from a patient''s mother via social media refers to her 14 year old daughter. There was no information about the patient''s concurrent conditions, concomitant therapies and medical history provided. The patient''s mother stated that, before the events, her daughter was a normal and healthy child. On an unknown date, the patient was vaccinated with a dose of GARDASIL intramuscularly (dose, lot # and expiration date were not reported). On an unknown date in March 206, after vaccination with GARDASIL, the patient experienced paralysis which began in her limbs and, as reported due to gravity, was hospitalized in intensive care unit (ICU) within 3 hours of reaching the hospital. Approximately in 2016, the patient underwent 4 bone marrow aspirates Guillain Barre and Lupus were suspected. The last 3 tests had results reported as altered (details not specified). At the time of the report (reported as currently), the patient presented face damage due to aggressive paralysis and her decreased mood. At the time of this report the outcome of the events was unknown and the patient was undiagnosed. Relatedness between the events and GARDASIL was not reported. The events of Guillain Barre and Lupus were determined to be medically significant and disabling. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166